JP5717317B2 - 化合物の医薬品的使用 - Google Patents

化合物の医薬品的使用 Download PDF

Info

Publication number
JP5717317B2
JP5717317B2 JP2008539185A JP2008539185A JP5717317B2 JP 5717317 B2 JP5717317 B2 JP 5717317B2 JP 2008539185 A JP2008539185 A JP 2008539185A JP 2008539185 A JP2008539185 A JP 2008539185A JP 5717317 B2 JP5717317 B2 JP 5717317B2
Authority
JP
Japan
Prior art keywords
extract
psidium
ethanol
inhibition
psidium guajava
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2008539185A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009514901A (ja
JP2009514901A5 (enExample
Inventor
アイデンバーガー，トーマス
Original Assignee
オムニカ ゲーエムベーハー
オムニカ ゲーエムベーハー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オムニカ ゲーエムベーハー, オムニカ ゲーエムベーハー filed Critical オムニカ ゲーエムベーハー
Publication of JP2009514901A publication Critical patent/JP2009514901A/ja
Publication of JP2009514901A5 publication Critical patent/JP2009514901A5/ja
Application granted granted Critical
Publication of JP5717317B2 publication Critical patent/JP5717317B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medical Informatics (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2008539185A 2005-11-09 2006-11-08 化合物の医薬品的使用 Active JP5717317B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ATA1833/2005 2005-11-09
AT0183305A AT502717A1 (de) 2005-11-09 2005-11-09 Pharmazeutische verwendung einer verbindung
PCT/AT2006/000454 WO2007053865A1 (en) 2005-11-09 2006-11-08 Pharmaceutical use of a compound

Publications (3)

Publication Number Publication Date
JP2009514901A JP2009514901A (ja) 2009-04-09
JP2009514901A5 JP2009514901A5 (enExample) 2012-12-27
JP5717317B2 true JP5717317B2 (ja) 2015-05-13

Family

ID=37876593

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008539185A Active JP5717317B2 (ja) 2005-11-09 2006-11-08 化合物の医薬品的使用

Country Status (4)

Country Link
US (1) US20090186110A1 (enExample)
JP (1) JP5717317B2 (enExample)
AT (1) AT502717A1 (enExample)
WO (1) WO2007053865A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080293644A1 (en) * 2007-04-27 2008-11-27 Thomas Eidenberger Guava extract
JP2010105922A (ja) * 2008-10-28 2010-05-13 Uha Mikakuto Co Ltd Ｌｏｘ−１アンタゴニスト作用剤
WO2012092389A2 (en) * 2010-12-28 2012-07-05 Mary Kay Inc. Sebum control and anti-acne composition
US8877259B2 (en) 2012-02-09 2014-11-04 Mary Kay Inc. Cosmetic formulation
CN103565928A (zh) * 2013-11-01 2014-02-12 华南农业大学 一种番石榴降糖活性组分、制备方法及用途
CN104173975A (zh) * 2014-08-25 2014-12-03 河南科技大学第一附属医院 一种用于治疗糖尿病的中药组合物
CA2979033A1 (en) 2015-03-09 2016-09-15 Intekrin Therapeutics, Inc. Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
DE102016102265A1 (de) 2016-02-10 2017-08-10 Pm-International Ag Zusammensetzung zur Reduzierung und/oder Hemmung einer intestinalen Glucose-Resorption, Nahrungsergänzungsmittel, Verwendung der Zusammensetzung und Verfahren zur Herstellung des Nahrungsergänzungsmittels
DE102016102271A1 (de) 2016-02-10 2017-08-10 Pm-International Ag Zusammensetzung zur Reduzierung und/oder Hemmung einer intestinalen Glucose-Resorption, Nahrungsergänzungsmittel, Verwendung der Zusammensetzung und Verfahren zur Herstellung des Nahrungsergänzungsmittels
WO2017137405A1 (de) 2016-02-10 2017-08-17 Pm-International Ag Zusammensetzung enthaltend guaijaverin zur reduzierung und/oder hemmung einer intestinalen glucose-resorption, nahrungsergänzungsmittel, verwendung der zusammensetzung und verfahren zur herstellung des nahrungsergänzungsmittels
CN110996951A (zh) 2017-04-03 2020-04-10 科赫罗斯生物科学股份有限公司 治疗进行性核上性麻痹的PPARγ激动剂
EP3829612A1 (de) * 2018-08-02 2021-06-09 PM-International AG Gänseblümchenextrakt

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4921475A (en) * 1983-08-18 1990-05-01 Drug Delivery Systems Inc. Transdermal drug patch with microtubes
US5087240A (en) * 1983-08-18 1992-02-11 Drug Delivery Systems Inc. Transdermal drug patch with conductive fibers
JPS6056923A (ja) * 1983-09-06 1985-04-02 Bizen Kasei Kk グアバ葉エキスの抽出方法
JPS6137731A (ja) * 1984-07-31 1986-02-22 Bizen Kasei Kk グアバ葉エキスを有効成分とする経口糖尿病薬
US5163899A (en) * 1987-03-20 1992-11-17 Drug Delivery Systems Inc. Transdermal drug delivery system
JPS63283563A (ja) * 1987-05-18 1988-11-21 Morishige Okinaga グァバ茶の製造方法
US5312325A (en) * 1987-05-28 1994-05-17 Drug Delivery Systems Inc Pulsating transdermal drug delivery system
GB8804164D0 (en) * 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US5008110A (en) * 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5088977A (en) * 1988-12-21 1992-02-18 Drug Delivery Systems Inc. Electrical transdermal drug applicator with counteractor and method of drug delivery
ATE107176T1 (de) * 1989-12-04 1994-07-15 Searle & Co System zur transdermalen albuterol applikation.
US5352456A (en) * 1991-10-10 1994-10-04 Cygnus Therapeutic Systems Device for administering drug transdermally which provides an initial pulse of drug
ATE132381T1 (de) * 1992-01-29 1996-01-15 Voelkl Franz Ski Ballspielschläger, insbesondere tennisschläger
JP3193441B2 (ja) * 1992-03-09 2001-07-30 御木本製薬株式会社 美白化粧料
JP4109731B2 (ja) * 1997-01-23 2008-07-02 備前化成株式会社 改良グアバ葉エキス抽出法
WO2001021608A2 (en) * 1999-09-23 2001-03-29 Vereniging Voor Christelijk Wetenschappelijk Onderwijs Novel flavonoids
DK1283735T4 (da) * 2000-03-31 2013-02-04 Royalty Pharma Collection Trust Fremgangsmåde til forbedring signalering af øceller ved diabetes mellitus og til forebyggelse deraf
ES2173047B1 (es) * 2001-03-21 2004-01-01 Aplicaciones Farmacodinamicas Procedimiento para la obtencion de las diferentes fracciones de guayaba atomizada y su uso para el tratamiento de la diabetes mellitus tipo ii
KR100443264B1 (ko) * 2001-06-07 2004-08-04 한국생명공학연구원 구아바로부터 얻은 단백질 타이로신 탈인산화 효소 １ｂ 저해용 활성분획 추출물
WO2006074278A2 (en) * 2005-01-05 2006-07-13 Mitsunori Ono Compositions for treating diabetes or obesity

Also Published As

Publication number Publication date
JP2009514901A (ja) 2009-04-09
US20090186110A1 (en) 2009-07-23
AT502717A1 (de) 2007-05-15
WO2007053865A1 (en) 2007-05-18
WO2007053865A9 (en) 2007-07-12

Similar Documents

Publication Publication Date Title
AU2004200624B2 (en) Medicinal preparation containing phenylethanoid glycosides extracted from herbaceous plant, cistanche tubulosa (schenk.) wight, process of making the same, and uses of the same
US10864241B2 (en) Use of tomato extract as antihypertensive agent and process for making water soluble sugar free tomato extract
US20070286911A1 (en) Huperzia serrate (thunb.) trev. composition comprising compounded huperzine a and huperzine b and methods for preparing it
WO2013100105A1 (ja) メイラード反応阻害剤
JP5717317B2 (ja) 化合物の医薬品的使用
US20080293644A1 (en) Guava extract
US6737085B2 (en) Apocynum venetum extract for use as antidepressant
KR19990085202A (ko) 치매병 예방 및 치료용 생약조성물
KR20000063097A (ko) 4'-0-메틸피리독신 및 비플라본 함량을 감소시킨 징코빌로바 잎 추출물 및 제조 방법
JP2011512347A (ja) エネルギー利用疾病の治療
WO2008145064A1 (en) The method for a sequoyitol-containing extract obtaining from the genus of trifolium, sobyean and ginkgo biloba and use thereof
JP4520089B2 (ja) ルブロフサリン配糖体含有組成物
JP2011037800A (ja) アピオス花を用いた血糖値上昇抑制物質および糖尿病予防用食品素材
JP5085120B2 (ja) 脳機能改善剤
JP2024105312A (ja) ナツメ属植物及びガラナの生物活性植物化学物質
JP3228534B2 (ja) 血中アルコール濃度低下用組成物
JP4524342B2 (ja) 大麦焼酎蒸留残液から分取した記憶学習能向上の薬理作用を呈する組成物
KR100908038B1 (ko) 당뇨성 합병증 예방 또는 치료용 곰피 추출물
JP2004024104A (ja) プロポリス抽出物、その製造方法、それを含有する血圧降下剤、食品製剤及びプロポリス組成物
EP1498131A1 (en) Medicinal preparation containing phenylethanoid glycosides extracted from Cistanche tubulosa
CN103193788B (zh) 一个具有神经保护作用的石蒜碱类化合物
KR100759468B1 (ko) 자색 고구마로부터 분리된 자색 색소를 함유하는 통풍 예방및 치료용 조성물
EP2340844A1 (en) Anti-avian influenza virus agent, and product containing anti-avian influenza virus agent
KR100657017B1 (ko) 도라지 추출물을 함유하는 ｌ-ｆａｂｐ 증강제 및 그 정제방법
KR100594989B1 (ko) 해조식물로부터 추출한 안지오텐신 전환효소 활성억제제를 함유하는 고혈압 개선제 및 이를 포함하는 제품

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090929

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090929

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120501

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120730

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120806

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120827

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120903

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120927

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121004

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121029

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20121029

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130514

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130913

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130926

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20131007

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20131206

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141014

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141017

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141114

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141119

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141210

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141215

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150116

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150317

R150 Certificate of patent or registration of utility model

Ref document number: 5717317

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250